Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association

Gia Mudd-Martin, Allison L. Cirino, Veronica Barcelona, Keolu Fox, Maui Hudson, Yan V. Sun, Jacquelyn Y. Taylor, Vicky A. Cameron

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Historically marginalized racial and ethnic groups and Indigenous peoples are burdened by significant health inequities that are compounded by their underrepresentation in genetic and genomic research. Of all genome-wide association study participants, ≈79% are of European descent, despite this group constituting only 16% of the global population. For underrepresented populations, polygenic risk scores derived from these studies are less accurate in predicting disease phenotypes, novel population-specific genetic variations may be misclassified as potentially pathogenic, and there is a lack of understanding of how different populations metabolize drugs. Although inclusion of marginalized racial and ethnic groups and Indigenous peoples in genetic and genomic research is crucial, scientific studies must be guided by ethical principles of respect, honesty, justice, reciprocity, and care for individuals and communities. Special considerations are needed to support research that benefits the scientific community as well as Indigenous peoples and marginalized groups. Before a project begins, collaboration with community leaders and agencies can lead to successful implementation of the study. Throughout the study, consideration must be given to issues such as implications of informed consent for individuals and communities, dissemination of findings through scientific and community avenues, and implications of community identity for data governance and sharing. Attention to these issues is critical, given historical harms in biomedical research that marginalized groups and Indigenous peoples have suffered. Conducting genetic and genomic research in partnership with Indigenous peoples and marginalized groups guided by ethical principles provides a pathway for scientific advances that will enhance prevention and treatment of cardiovascular disease for everyone.

Original languageEnglish
Pages (from-to)E000084
JournalCirculation. Genomic and precision medicine
Volume14
Issue number4
DOIs
StatePublished - Aug 1 2021

Bibliographical note

Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.

Funding

NZ Ministry of Business, Innovation and Employment (MBIE) (co-PI of cardiovascular research within the National Science Challenge: Healthier Lives, 2020–2023, reducing health inequities for Māori and Pacific peoples)†; Lotteries Health New Zealand (PI, study of DNA methylation in very-low-birth-weight cohort)†; Health Research Council of New Zealand (named investigator on project grant: Environmental Effects of Cardiometabolic Biomarkers in Pacific Peoples)†; Health Research Council of New Zealand (named investigator on project grant: A Precision Medicine Approach to Improving Heart Disease Outcomes)†

FundersFunder number
Lotteries Health New Zealand
Health Research Council of New Zealand
Ministry of Business, Innovation and Employment

    Keywords

    • AHA Scientific Statements
    • Indigenous peoples
    • ethics
    • genetic research
    • genomics
    • population groups
    • racial and ethnic groups

    ASJC Scopus subject areas

    • Genetics
    • Cardiology and Cardiovascular Medicine
    • Genetics(clinical)

    Fingerprint

    Dive into the research topics of 'Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association'. Together they form a unique fingerprint.

    Cite this